Health-related quality of life of thyroid cancer patients undergoing radioiodine therapy: a cohort real-world study in a reference public cancer hospital in Brazil

Ramim, Jayda Eiras; Cardoso, Marcella Araugio Soares; Oliveira, Gessen Lopes Carneiro de; Gomes, M. L.; Guimarães, Tiago; Mello, Renata; Bergmann, Anke; Pujatti, Priscilla Brunelli

doi:10.1007/s00520-019-05225-x

Cited by 7 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Radioactive iodine treatment (RAI) has been extensively studied as a predictive and protective factor of QoL among TC patients. While some studies have reported improvements in QoL and emotional and cognitive function after RAI treatment, patients have also reported significant side effects such as nausea, vomiting, and RAI-induced xerostomia [ 29 , 42 ] that negatively impact QoL. Banihashem et al .…”

Section: Resultsmentioning

confidence: 99%

The "not so good" thyroid cancer: a scoping review on risk factors associated with anxiety, depression and quality of life

et al. 2023

View full text Add to dashboard Cite

The incidence of thyroid cancer has increased in recent years, leading to a growing number of survivors facing lifelong consequences. This scoping review investigated anxiety, depression, and quality of life (QoL) in thyroid cancer survivors compared to the general population, those with benign pathology, and survivors of other types of cancers. Moreover, we aimed to identify the risk factors associated with anxiety, depression, and QoL in thyroid cancer patients. A total of 727 articles were identified through PubMed, ProQuest, Cochrane, and Google Scholar databases, and 68 articles that met the criteria were selected for data extraction. Thyroid cancer survivors have a poorer QoL compared to the general population, population with benign pathology, and survivors of other types of cancer associated with worse clinical outcomes. The main risk factors are grouped into socioeconomic factors, disease-specific factors, management factors, comorbidities, and patient perceptions. Effective communication between the patient and the medical team and behavioral interventions may reduce these risks. Despite the common perception of thyroid cancer as a "good cancer," the findings of this review demonstrate the need to address the risk factors associated with increased anxiety, depression, and lower QoL in survivors.

show abstract

Section: Resultsmentioning

confidence: 99%

The "not so good" thyroid cancer: a scoping review on risk factors associated with anxiety, depression and quality of life

et al. 2023

View full text Add to dashboard Cite

show abstract

“…9,10 In addition, after RIT, most patients with DTC become cancer survivors because this is an indolent type of cancer that presents low mortality, high overall survival rates, and disease-free survival of over 90% in five years. 8,11,12 This causes DTC survivors to demand a long-term follow-up in the post-RIT period. 3 In view of the clinical and pharmacotherapeutic needs of patients with DTC who undergo RIT, a radiopharmacy service began to offer comprehensive medication management (CMM) to these individuals.…”

Section: Introductionmentioning

confidence: 99%

Clinical pharmaceutical screening in critical situations in a radioiodine therapy management service

Fontes

Oliveira

Rezende

et al. 2021

J Oncol Pharm Pract

Self Cite

View full text Add to dashboard Cite

Radioiodine therapy can be used in differentiated thyroid carcinoma and requires extensive evaluation to ensure effectiveness and safety. Therefore, it is necessary to evaluate all health problems and medications used in the pre-radioiodine therapy period and comprehensive medication managementservices can serve as a screening tool in this context. The present study aims to describe critical clinical situations identified during the initial assessments of a comprehensive medication management service offered to differentiated thyroid carcinoma patients pre-radioiodine therapy, and the pharmaceutical interventions performed to solve them. A descriptive study with regard to the initial ten months of a comprehensive medication management service was carried out in a large oncology hospital (Rio de Janeiro, Brazil). Descriptive analysis was used to describe the critical clinical situations identified, as well as the correspondent drug therapy problems and the type, acceptability, and outcomes of the pharmaceutical interventions performed to solve them. Thirty patients with an average of 45.8 years and 5.1 medications were evaluated. Five critical clinical situations were identified; corresponding to drug therapy problems two(needs additional drug therapy – n = 4) and drug therapy problems four (dosage too low – n = 1). All pharmaceutical interventions were accepted. The comprehensive medication management service provision pre-radioiodine therapy is feasible and represents an important screening strategy.

show abstract

Quality of life of patients with thyroid cancer in Colombia

Gómez,

Sanabria

2024

Endocrinología, Diabetes y Nutrición (English ed.)

View full text Add to dashboard Cite

Health-related quality of life of thyroid cancer patients undergoing radioiodine therapy: a cohort real-world study in a reference public cancer hospital in Brazil

Cited by 7 publications

References 27 publications

The "not so good" thyroid cancer: a scoping review on risk factors associated with anxiety, depression and quality of life

The "not so good" thyroid cancer: a scoping review on risk factors associated with anxiety, depression and quality of life

Clinical pharmaceutical screening in critical situations in a radioiodine therapy management service

Quality of life of patients with thyroid cancer in Colombia

Contact Info

Product

Resources

About